These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19967814)

  • 1. [The evolution of ideas about nonalcohol fatty liver disease].
    Podymova SD
    Eksp Klin Gastroenterol; 2009; (4):4-12. PubMed ID: 19967814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fatty hepatosis. Non-alcoholic steatohepatitis (evolution of the knowledge about clinico-morphological features, prognosis, treatment)].
    Podymova SD
    Ter Arkh; 2006; 78(4):32-8. PubMed ID: 16821419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.
    Angulo P; Keach JC; Batts KP; Lindor KD
    Hepatology; 1999 Dec; 30(6):1356-62. PubMed ID: 10573511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low clinical relevance of the nonalcoholic fatty liver disease activity score (NAS) in predicting fibrosis progression.
    Ekstedt M; Franzén LE; Mathiesen UL; Kechagias S
    Scand J Gastroenterol; 2012 Jan; 47(1):108-15. PubMed ID: 22126450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis.
    Contos MJ; Cales W; Sterling RK; Luketic VA; Shiffman ML; Mills AS; Fisher RA; Ham J; Sanyal AJ
    Liver Transpl; 2001 Apr; 7(4):363-73. PubMed ID: 11303298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.
    Malik SM; Devera ME; Fontes P; Shaikh O; Sasatomi E; Ahmad J
    Liver Transpl; 2009 Dec; 15(12):1843-51. PubMed ID: 19938117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies.
    Fassio E; Alvarez E; Domínguez N; Landeira G; Longo C
    Hepatology; 2004 Oct; 40(4):820-6. PubMed ID: 15382171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural history of nonalcoholic fatty liver: a follow-up study.
    Teli MR; James OF; Burt AD; Bennett MK; Day CP
    Hepatology; 1995 Dec; 22(6):1714-9. PubMed ID: 7489979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease.
    Yalamanchili K; Saadeh S; Klintmalm GB; Jennings LW; Davis GL
    Liver Transpl; 2010 Apr; 16(4):431-9. PubMed ID: 20373454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].
    Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J
    Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic evaluation of nonalcoholic fatty liver disease.
    Adams LA; Talwalkar JA
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S34-8. PubMed ID: 16540765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease: is all the fat bad?
    Clouston AD; Powell EE
    Intern Med J; 2004 Apr; 34(4):187-91. PubMed ID: 15086699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nonalcoholic fatty liver].
    Dancygier H
    Versicherungsmedizin; 2002 Mar; 54(1):11-5. PubMed ID: 11933860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee.
    Loria P; Adinolfi LE; Bellentani S; Bugianesi E; Grieco A; Fargion S; Gasbarrini A; Loguercio C; Lonardo A; Marchesini G; Marra F; Persico M; Prati D; Baroni GS;
    Dig Liver Dis; 2010 Apr; 42(4):272-82. PubMed ID: 20171943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of L-tryptophan and melatonin on selected biochemical parameters in patients with steatohepatitis.
    Cichoz-Lach H; Celinski K; Konturek PC; Konturek SJ; Slomka M
    J Physiol Pharmacol; 2010 Oct; 61(5):577-80. PubMed ID: 21081801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty liver disease in morbid obesity.
    Clain DJ; Lefkowitch JH
    Gastroenterol Clin North Am; 1987 Jun; 16(2):239-52. PubMed ID: 3319904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-alcoholic fatty liver disease in dyslipidemia and insulin resistance: similarities and differences; differential approach to therapy].
    Lazebnik LB; Zvenigorodskaia LA; Egorova EG; Mel'nikova NV; Khomeriki SG
    Eksp Klin Gastroenterol; 2009; (8):4-11. PubMed ID: 20469672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality.
    Younossi ZM; Stepanova M; Rafiq N; Makhlouf H; Younoszai Z; Agrawal R; Goodman Z
    Hepatology; 2011 Jun; 53(6):1874-82. PubMed ID: 21360720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years.
    Furuya CK; de Oliveira CP; de Mello ES; Faintuch J; Raskovski A; Matsuda M; Vezozzo DC; Halpern A; Garrido AB; Alves VA; Carrilho FJ
    J Gastroenterol Hepatol; 2007 Apr; 22(4):510-4. PubMed ID: 17376042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.